ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Shubik applauded for NCAB Service

February 12, 1982

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

NCI Begins Latin American Cancer Research Network

April 10, 2009

Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation

November 27, 1987

UICC Names Banker As Chief Executive

September 11, 2009

Nominations sought for NCI consumer liaison group.

January 9, 2004